ST红太阳(000525) - 2025 Q2 - 季度业绩预告

Current Period Performance Forecast The company anticipates a significant loss for the first half of 2025, with net profit attributable to shareholders projected to be a loss of RMB 168 million to RMB 228 million, a substantial reversal from the RMB 21.232 million profit in the same period last year Performance Forecast Comparison | Item | Current Period (2025 H1 Forecast) | Prior Period (2024 H1) | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders of Listed Company (RMB million) | Loss: 168 - 228 | Profit: 21.232 | | Net Profit After Deducting Non-Recurring Gains and Losses (RMB million) | Loss: 196 - 256 | Profit: 18.9816 | | Basic Earnings Per Share (RMB/share) | Loss: 0.1294 - 0.1757 | Profit: 0.0366 | Communication with Accounting Firm The performance forecast data represents preliminary estimates by the company's finance department and has not been pre-audited by an accounting firm, with accuracy subject to final report confirmation - The performance forecast data is a preliminary estimate by the company's finance department and has not been pre-audited by an accounting firm[4] Explanation of Performance Change The decline in performance is primarily attributed to intensified market competition, leading to low prices, lower-than-expected gross margins and operating rates for key products, increased costs from strategic investments in technology upgrades and new projects for long-term development, and limited financing due to ongoing credit restoration post-reorganization - Intense market competition and supply-side capacity expansion have resulted in low prices for some of the company's main products, leading to lower-than-expected gross margins and operating rates[5] - Although prices for chlorantraniliprole industry chain products have risen, their limited volume has resulted in insufficient contribution to current period performance and a lagging effect[5] - To promote future development, the company has increased investment in technology upgrades, product innovation, and new base construction, leading to higher related expenditures and operating costs, which have impacted overall operating efficiency[5] - The company's credit restoration post-reorganization is ongoing, resulting in limited incremental financing and exerting pressure on short-term performance[5] Risk Warning The company explicitly states that this performance forecast is a preliminary estimate, with final accurate financial data to be detailed in the 2025 semi-annual report, advising investors to exercise caution and be aware of investment risks - The performance forecast data is a preliminary estimate by the company's finance department, with final data subject to the 2025 semi-annual report[6] - The company reminds investors to make cautious decisions and be aware of investment risks[6]